Related Experiment Video
Updated: Jun 6, 2026
05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies.
1European Medicines Agency, London, UK. priya.bahri@ema.europa.eu
Drug Safety
|November 17, 2010
Summary
This study proposes a strategic health communication approach to improve safe medicine use. It emphasizes measurable objectives, evidence-based design, and patient involvement for effective public health interventions.
Area of Science:
- Public Health Communication
- Pharmacovigilance
- Health Behavior
Background:
- Effective communication on medicine use is crucial for patients, healthcare professionals, and the public.
- Current communication strategies may not adequately address patient concerns or persistent unfavorable medicine use patterns.
Purpose of the Study:
- To propose and test a strategic health communication approach for improving the effective and safe use of medicines.
- To distinguish between communication and transparency purposes in health information dissemination.
- To encourage organizations to adapt this approach for their specific remits and legal obligations.
Main Methods:
- Developing a strategic health communication approach with measurable objectives and shared problem ownership.
- Utilizing an evidence base from drug utilization, decision-making, risk perception research, and patient/professional participation.
- Implementing a cyclic process for planning, implementation, and evaluation of communication as a public health intervention.
Main Results:
- The proposed approach integrates risk assessment with evidence from user research for situation-specific safety communication.
- It emphasizes addressing practical concerns of medicine users to develop behavior change models.
- Two-way communication models are explored to inform risk assessment and management.
Conclusions:
- A strategic, evidence-based, and participatory communication approach can enhance medicine safety and effectiveness.
- The pharmacovigilance community should lead in advancing risk management through improved public communication.
- Long-term success requires mixed media, message repetition, inter-system cooperation, and continuous evaluation.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).